Form DEFR14C - Revised information statement materials, definitive:
SEC Accession No. 0001144204-03-005208
Filing Date
2003-08-29
Accepted
2003-08-29 14:52:37
Documents
1
Effectiveness Date
2003-08-29

Document Format Files

Seq Description Document Type Size
1 doc1.txt DEFR14C 57499
  Complete submission text file 0001144204-03-005208.txt   59098
Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170 212-297-6221
HEMOXYMED INC (Filer) CIK: 0000872947 (see all company filings)

EIN.: 391661164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14C | Act: 34 | File No.: 001-13835 | Film No.: 03873949
SIC: 2836 Biological Products, (No Diagnostic Substances)